Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT05038462

Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth Restriction

Led by Institut d'Investigacions Biomèdiques August Pi i Sunyer · Updated on 2024-03-18

304

Participants Needed

6

Research Sites

201 weeks

Total Duration

On this page

Sponsors

I

Institut d'Investigacions Biomèdiques August Pi i Sunyer

Lead Sponsor

F

Fundacion Clinic per a la Recerca Biomédica

Collaborating Sponsor

AI-Summary

What this Trial Is About

Singleton pregnancies being diagnosed of fetal growth restriction from 24 to 32.6 weeks of gestation will be randomized to two equally sized groups: maternal oral supplementation with Lactoferrin and DHA (Docosahexaenoic acid) or placebo.

CONDITIONS

Official Title

Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth Restriction

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Singleton pregnancies
  • Non-malformed fetus
  • Pregnancies diagnosed with fetal growth restriction
  • Gestational age between 24 and 32.6 weeks
Not Eligible

You will not qualify if you...

  • Chromosomal or structural abnormalities diagnosed during pregnancy or neonatal period
  • Critical Doppler findings suggesting delivery needed within 14 days (reverse end-diastolic velocity in umbilical artery or ductus venosus pulsatility >95th centile)
  • Maternal mental or psychiatric disorders
  • Maternal allergy to cow's milk protein

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Hospital Clínic de Barcelona

Barcelona, Spain

Actively Recruiting

2

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

Actively Recruiting

3

Hospital del Mar

Barcelona, Spain

Actively Recruiting

4

Hospital Dexeus-Quirón

Barcelona, Spain

Actively Recruiting

5

Hospital Sant Joan de Déu

Esplugues de Llobregat, Spain

Actively Recruiting

6

Hospital General del Hospitalet

L'Hospitalet de Llobregat, Spain

Actively Recruiting

Loading map...

Research Team

E

Elisenda Eixarch, MD; PhD

CONTACT

E

Elena Monterde, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here